Biotricity is trading 10% up at $0.06, with no current company-specific catalyst identified. - The company’s newsroom shows no announcement dated October 26, 2026; its October 26 listing is from 2022. - Broader indexes are modestly higher, but none is up more than 0.5%, and available evidence does not establish a market-wide reason for the move.